NCT04842890View on ClinicalTrials.gov

Phase II Study of Pencil Beam Scanning Proton Stereotactic Body Radiation Therapy for Prostate Cancer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

January 8, 2021

Primary Completion Date

June 30, 2026

Study Completion Date

January 31, 2031

Conditions
Prostate Cancer
Interventions
RADIATION

Pencil Beam Scanning Proton SBRT

The intervention being investigated is ultra-hypofractionated, image-guided, pencil beam scanning proton SBRT directed at the prostate gland and seminal vesicles to 40 Gy equivalent in 5 fractions, delivered every other day.

Trial Locations (1)

10035

The New York Proton Center, New York

All Listed Sponsors
lead

The New York Proton Center

OTHER